New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Steepest annual rise in advanced cervical cancer in US among White women

Steepest annual rise in advanced cervical cancer in US among White women

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainThe steepest annual rise in new cases of advanced womb (cervical) cancer in the US is among White women, who are significantly less lik
World medicine December 16,2023
Steepest annual rise in advanced cervical cancer in US among White women

Steepest annual rise in advanced cervical cancer in US among White women

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainThe steepest annual rise in new cases of advanced womb (cervical) cancer in the US is among White women, who are significantly less lik
World medicine December 16,2023
Harnessing the immune system to fight cancer

Harnessing the immune system to fight cancer

by Madeleine Turner,Whitehead Institute for Biomedical ResearchCredit: Gretchen Ertl/ Whitehead InstituteSometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni
World medicine December 16,2023
Harnessing the immune system to fight cancer

Harnessing the immune system to fight cancer

by Madeleine Turner,Whitehead Institute for Biomedical ResearchCredit: Gretchen Ertl/ Whitehead InstituteSometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni
World medicine December 16,2023
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainThe highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses i
World medicine December 16,2023
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainThe highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses i
World medicine December 16,2023
Researchers develop a small molecule that could make immunotherapy available to all cancer patients

Researchers develop a small molecule that could make immunotherapy available to all cancer patients

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more access
World medicine December 16,2023
Researchers develop a small molecule that could make immunotherapy available to all cancer patients

Researchers develop a small molecule that could make immunotherapy available to all cancer patients

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more access
World medicine December 16,2023
FLASH radiation therapy shows promise in first-in-human trial

FLASH radiation therapy shows promise in first-in-human trial

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainFLASH radiation treatment—which delivers therapeutic doses of radiation in a fraction of a second—may hold promise as a
World medicine December 16,2023
FLASH radiation therapy shows promise in first-in-human trial

FLASH radiation therapy shows promise in first-in-human trial

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainFLASH radiation treatment—which delivers therapeutic doses of radiation in a fraction of a second—may hold promise as a
World medicine December 16,2023
Pathogenic germline variants identified in patients with lung cancer

Pathogenic germline variants identified in patients with lung cancer

A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable, according to a study presented Aug. 16 as part of the
World medicine December 16,2023
Pathogenic germline variants identified in patients with lung cancer

Pathogenic germline variants identified in patients with lung cancer

A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable, according to a study presented Aug. 16 as part of the
World medicine December 16,2023
'Inside out' signaling promotes tumor growth

'Inside out' signaling promotes tumor growth

by Will Doss,Northwestern UniversityPharmacological inhibitor of MLCK MW01-022AZ suppressed tumor inflammation and growth. a Schematic of LLC lung tumor implantation in C57Bl6 mice and MW01-022A
World medicine December 16,2023
'Inside out' signaling promotes tumor growth

'Inside out' signaling promotes tumor growth

by Will Doss,Northwestern UniversityPharmacological inhibitor of MLCK MW01-022AZ suppressed tumor inflammation and growth. a Schematic of LLC lung tumor implantation in C57Bl6 mice and MW01-022A
World medicine December 16,2023
New chip could make treating metastatic cancer easier and faster

New chip could make treating metastatic cancer easier and faster

byGeorgia Institute of TechnologyFabrication of the microchip. The device is fabricated by injecting a polymer into a micro fabricated mold and the polymer is cured under ultraviolet light to pr
World medicine December 16,2023
New chip could make treating metastatic cancer easier and faster

New chip could make treating metastatic cancer easier and faster

byGeorgia Institute of TechnologyFabrication of the microchip. The device is fabricated by injecting a polymer into a micro fabricated mold and the polymer is cured under ultraviolet light to pr
World medicine December 16,2023
Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

byUniversity of ExeterCredit: Pixabay/CC0 Public DomainMen at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practic
World medicine December 16,2023
Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

byUniversity of ExeterCredit: Pixabay/CC0 Public DomainMen at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practic
World medicine December 16,2023
Researchers study rare genetic condition to tackle colorectal cancer

Researchers study rare genetic condition to tackle colorectal cancer

by Joe Dangor,Mayo ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers from the Mayo Clinic Comprehensive Cancer Center and the Mayo Clinic Center
World medicine December 16,2023
Researchers study rare genetic condition to tackle colorectal cancer

Researchers study rare genetic condition to tackle colorectal cancer

by Joe Dangor,Mayo ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers from the Mayo Clinic Comprehensive Cancer Center and the Mayo Clinic Center
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com